This page contains content forconsumers. Do you want to continue?
Improved sequencing success begins with reliably effective solutions
Our innovative and automation-friendly workflow with our new KAPA Target Enrichment products is compatible with a variety of sample inputs, able to free-up time and resources to give you greater peace of mind
Next-generation sequencing (NGS) is driving advances in translational and clinical research. From expanding our understanding of cancer, reproductive and developmental biology to unravelling complex microbial populations, NGS is touching all facets of human disease and wellbeing.
Sample prep for next generation sequencing holds the key to unlocking the potential of every sample. Explore our integrated Roche Sample Preparation Solutions, encompassing all the steps required to convert a sample to a sequencing-ready library. From sample collection to library quantification, we offer sample prep solutions for different sample types and sequencing applications that are proven, simple and complete.
Identifying Host Genetic Factors in COVID-19 with NGS
By using next-generation sequencing (NGS), scientists can become more informed about how host genetic factors play a role in disease severity and susceptibility.
Roche launches new Exome and Custom KAPA Target Enrichment portfolio for translational and clinical research applications in sequencing
Roche announces the launch of the new KAPA Target Enrichment portfolio, consisting of both exome and custom target enrichment solutions for sequencing.
What is NGS Target Enrichment and why is it important?
Next-generation sequencing (NGS) has enabled large-scale sequencing within a couple of days and it has also lowered the cost of sequencing considerably.